Prioritizing oral bioavailability in drug development strategies
Future Medicinal Chemistry · 17.01.2025 · 17 (2) · 149-151
DOI: 10.1080/17568919.2024.2444871 ↗Kurz gefasst
Editorial in der Zeitschrift Future Medicinal Chemistry, online erschienen am 26.12.2024. Verfasst von Lijuan Xie und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, PR China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
1. The development of innovative drugs represents a strategic high ground in the current international competition in science and technology, significantly impacting economic development and social...
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, PR China.
- Yunnan Key Laboratory of Stem Cell and Regenerative Medicine & School of Rehabilitation, Kunming Medical University, Kunming, PR China.
Zitieren
APA
Xie, L., Hong, Y., Hu, Y., Li, H., Lou, J., & Zhou, X. (2025). Prioritizing oral bioavailability in drug development strategies. Future Medicinal Chemistry, 17(2), 149-151. https://doi.org/10.1080/17568919.2024.2444871
Vancouver
Xie L, Hong Y, Hu Y, Li H, Lou J, Zhou X. Prioritizing oral bioavailability in drug development strategies. Future Medicinal Chemistry. 2025;17(2):149-151. doi:10.1080/17568919.2024.2444871
BibTeX
@article{Xie2025,
author = {Xie, Lijuan and Hong, Yingjing and Hu, Yun and Li, Hongmei and Lou, Jie and Zhou, Xing},
title = {Prioritizing oral bioavailability in drug development strategies},
journal = {Future Medicinal Chemistry},
year = {2025},
volume = {17},
number = {2},
pages = {149--151},
doi = {10.1080/17568919.2024.2444871}
}
EUVIMED